Corneal Ulcer

Approved for this indication (2)

• gentamicin
• ofloxacin

Phase 4 trials (4)

• prednisone
• platelet-rich plasma
• moxifloxacin
• cenegermin-bkbj

Phase 3 trials (4)

• natamycin
• cyclosporine
• riboflavin
• voriconazole

Phase 2 trials (7)

• amniotic membrane
• besifloxacin
• bone marrow derived mesenchymal stem cells
• iodine
• ciprofloxacin
• gatifloxacin
• autologous adipose-derived mesenchymal stem cells

Phase 1 trials (2)

• human fibrin
• sygelix-coll-t

Other trials (3)

• naltrexone
• collagen
• methylcellulose

Organization Involved with Phase 4 Indications (3)

• Dartmouth University
• University of California, San Francisco
• Aravind Eye Hospital

Organization Involved with Phase 3 Indications (5)

• National Eye Institute (NEI)
• Los Angeles Biomedical Research Institute
• University of California, Los Angeles
• Lumbini Eye Institute and Hospital
• Bharatpur Eye Hospital, Nepal

Organization Involved with Phase 2 Indications (12)

• Bausch & Lomb
• Allergan
• Cornea Consultants Of Nashville
• University of the Philippines
• Belarusian State Medical University
• SCRI Development Innovations
• L. V. Prasad Eye Institute
• Thrasher Research Fund
• Kolokotrones Family Foundation
• Joseph Eye Hospital
• Dompe Pharmaceuticals
• National Academy of Sciences of Belarus

Organization Involved with Phase 1 Indications (3)

• Columbia University
• National Taiwan University
• University of Montreal